Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00996307 · ClinicalTrials.gov registry record · Phase 2
Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months
A Phase 2 study, sponsored by Novartis Vaccines.
- Completed
- Registry status
- Phase 2
- Development phase
- 654
- Enrollment target
NCT00996307 is a Phase 2 study that has completed, run by Novartis Vaccines. The registered enrollment target is 654 participants.
The verdict
NCT00996307, a Phase 2 study, has completed, sponsored by Novartis Vaccines.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 654 participants
- Enrollment target
Study Summary
This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 2009 (swine flu) vaccine in healthy young children
Interventions
- BIOLOGICAL MF59-eH1N1_f
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 654 participants |
| Start Date | 2009-10 |
| Est. Completion | 2010-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00996307
The ClinicalTrials.gov registry entry for NCT00996307 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 654 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Novartis Vaccines, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which MF59-eH1N1_f is the first listed.
NCT00996307 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00996307 about?
NCT00996307 is a clinical study titled "Pivotal, Multicenter, Observer-Blind, Randomized Study of Influenza A (H1N1)2009 Monovalent Subunit Vaccine With and Without Adjuvant in Children Ages 6 to <36 Months". This study will evaluate the safety and immunogenicity of different combinations of A/H1N1 2009 (swine flu) vaccine in healthy young children
What is the current status of trial NCT00996307?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 654 participants. The study started on 2009-10. Estimated completion is 2010-12.
What interventions are being tested in trial NCT00996307?
The interventions under investigation include: MF59-eH1N1_f (BIOLOGICAL).
Who is sponsoring clinical trial NCT00996307?
This trial is sponsored by Novartis Vaccines, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.